Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Ontiveros-Padilla

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 20, 2024
Microparticle and nanoparticle-based influenza vaccinesLuis Ontiveros-Padilla, Eric M Bachelder, Kristy M Ainslie
International Journal of Pharmaceutics|February 12, 2020
Development and in vitro evaluation of a new adjuvant system containing Salmonella Typhi porins and chitosanSelin Yüksel, Mert Pekcan, Nuhan Puralı, et al.
International Journal of Pharmaceutics|November 4, 2023
In vivo evaluation of new adjuvant systems based on combination of Salmonella Typhi porins with particulate systems: Liposomes versus polymeric particlesSelin Parmaksız, Mert Pekcan, Aykut Özkul, et al.
International Journal of Pharmaceutics|January 24, 2024
Comparative study of acetalated-dextran microparticle fabrication methods for a clinically translatable subunit-based influenza vaccineErik S Pena, Cole J Batty, Dylan A Hendy, et al.
Microorganisms|April 30, 2021
CD4+ and CD8+ Circulating Memory T Cells Are Crucial in the Protection Induced by Vaccination with <i>Salmonella</i> Typhi PorinsLuis Ontiveros-Padilla, Alberto García-Lozano, Araceli Tepale-Segura, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 7, 2025
Optimizing delivery in a multivalent subunit influenza vaccine using mixed polymeric microparticle degradation ratesErik S Pena, Luis Ontiveros-Padilla, Nicole R Lukesh, et al.
Advanced Therapeutics|March 6, 2026
COBRA Hemagglutinin and cGAMP Loaded Ace-DEX Microparticles Provide a Broadly Active and Shelf-Stable Influenza Vaccine PlatformDylan A Hendy, Erik S Pena, Cole J Batty, et al.
International Journal of Pharmaceutics|April 3, 2024
Enhancement of subunit vaccine delivery with zinc-carnosine coordination polymer through the addition of mannanJohn A Roque, Nicole Rose Lukesh, Dylan A Hendy, et al.
ACS Nano|January 15, 2025
Induction of Antigen-Specific Tolerance in a Multiple Sclerosis Model without Broad ImmunosuppressionRebeca T Stiepel, Sean R Simpson, Nicole Rose Lukesh, et al.
Frontiers in Immunology|April 10, 2023
Development of a broadly active influenza intranasal vaccine adjuvanted with self-assembled particles composed of mastoparan-7 and CpGLuis Ontiveros-Padilla, Cole J Batty, Dylan A Hendy, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 20, 2024
Microparticle and nanoparticle-based influenza vaccinesLuis Ontiveros-Padilla, Eric M Bachelder, Kristy M Ainslie
International Journal of Pharmaceutics|February 12, 2020
Development and in vitro evaluation of a new adjuvant system containing Salmonella Typhi porins and chitosanSelin Yüksel, Mert Pekcan, Nuhan Puralı, et al.
International Journal of Pharmaceutics|November 4, 2023
In vivo evaluation of new adjuvant systems based on combination of Salmonella Typhi porins with particulate systems: Liposomes versus polymeric particlesSelin Parmaksız, Mert Pekcan, Aykut Özkul, et al.
International Journal of Pharmaceutics|January 24, 2024
Comparative study of acetalated-dextran microparticle fabrication methods for a clinically translatable subunit-based influenza vaccineErik S Pena, Cole J Batty, Dylan A Hendy, et al.
Microorganisms|April 30, 2021
CD4+ and CD8+ Circulating Memory T Cells Are Crucial in the Protection Induced by Vaccination with <i>Salmonella</i> Typhi PorinsLuis Ontiveros-Padilla, Alberto García-Lozano, Araceli Tepale-Segura, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 7, 2025
Optimizing delivery in a multivalent subunit influenza vaccine using mixed polymeric microparticle degradation ratesErik S Pena, Luis Ontiveros-Padilla, Nicole R Lukesh, et al.
Advanced Therapeutics|March 6, 2026
COBRA Hemagglutinin and cGAMP Loaded Ace-DEX Microparticles Provide a Broadly Active and Shelf-Stable Influenza Vaccine PlatformDylan A Hendy, Erik S Pena, Cole J Batty, et al.
International Journal of Pharmaceutics|April 3, 2024
Enhancement of subunit vaccine delivery with zinc-carnosine coordination polymer through the addition of mannanJohn A Roque, Nicole Rose Lukesh, Dylan A Hendy, et al.
ACS Nano|January 15, 2025
Induction of Antigen-Specific Tolerance in a Multiple Sclerosis Model without Broad ImmunosuppressionRebeca T Stiepel, Sean R Simpson, Nicole Rose Lukesh, et al.
Frontiers in Immunology|April 10, 2023
Development of a broadly active influenza intranasal vaccine adjuvanted with self-assembled particles composed of mastoparan-7 and CpGLuis Ontiveros-Padilla, Cole J Batty, Dylan A Hendy, et al.
Pageof 2